With vaccine revenue crumbling and layoffs in full swing, is Moderna’s slimmed-down strategy a smart move or a red flag for ...

Termination of contracts and “de-scoping” of mRNA-related work in existing contracts, along with other changes, will affect ...

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...

According to TipRanks.com, Richter is a 4-star analyst with an average return of 8.8% and a 42.9% success rate. Richter covers the Healthcare sector, focusing on stocks such as Ultragenyx ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...

RNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of ...

The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...

The decision by US President Donald Trump’s administration to terminate 22 federal contracts for mRNA-based vaccines is a ...